Business segments
Topics
Time span
News 0 - 0 of 0 |
Open order serviceAt Fresenius, we are at the heart of healthcare. For all our activities, our patients take center stage. We focus on world-class therapies, which we continuously improve to keep pace with the major trends in healthcare. Our therapy focus is reflected in three platforms:
(Bio)Pharma
Biosimilars
IV Generics and Fluids
Clinical Nutrition
MedTech
Infusion and Nutrition Systems
Transfusion Medicine and Cell Therapies
Care Provision
Inpatient and Outpatient Treatments
Occupational Healthcare and Prevention
Reproductive Medicine
Furthermore, our Investment Company Fresenius Vamed expands our offering to:
Project Business and Services
Rehabilitation, Care and Health Tourism
An open dialog with our shareholders and the financial community is important to us. The Fresenius Investor Relations team will be happy to answer all your questions and inquiries.
You can submit your Feedback quickly and easily (anonymously if you prefer). You will be redirected to QuantiFire which conducts this survey in own controllership.
Fresenius SE & Co. KGaA
Investor Relations
Else-Kröner-Str. 1
D-61352 Bad Homburg
Germany
ir-fre@fresenius.com
Postal address:
Fresenius SE & Co. KGaA
Investor Relations
D-61346 Bad Homburg v.d.H.
Nick Stone
Senior Vice President Investor Relations
Head of Investor Relations
T: +49 (0) 6172 608-97033
nick.stone@fresenius.com
Karen Janek
Assistant Investor Relations
T: +49 (0) 6172 608-2487
karen.janek@fresenius.com
Florian Feick
Vice President Investor Relations
Deputy Head of Investor Relations
T: +49 (0) 6172 608-5167
florian.feick@fresenius.com
Kacper Boborykin
Director Investor Relations
(US based)
T: +1 224 566 1998
kacper.boborykin@fresenius.com
Stefanie Drees
Director Investor Relations
T: +49 (0) 6172 608-5211
stefanie.drees@fresenius.com
Felix Klein
Director Investor Relations
T: +49 (0) 6172 608-96484
felix.klein@fresenius.com
Michael Otto
Director Investor Relations
T: +49 (0) 6172 608-2419
michael.otto@fresenius.com
Elisabeth Truckenbrodt
Director Investor Relations
T: +49 (0) 6172 608-2486
elisabeth.truckenbrodt@fresenius.com
Mara Sinsel
Senior Manager Investor Relations
T: +49 (0) 6172 608-96538
mara.sinsel@fresenius.com
Luca Thorißen
Senior Manager Investor Relations
T +49 6172 608-97049
luca.thorissen@fresenius.com
Elisabeth Jung
Senior Manager Investor Relations
T: +49 (0) 6172 608-2421
elisabeth.jung@fresenius.com
Annette Hainz
Manager Investor Relations
T: +49 (0) 6172 608-2604
annette.hainz@fresenius.com